NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Bath & Body Works, Inc. (NYSE: BBWI)? Did you purchase your shares between June 4, 2024 and November 19, 2025, inclusive? Did you lose money in your investment in Bath & Body Works, Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI) investors of an upcoming dead ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against SLM Corporation (Sallie Mae) for alleged misrepresentations regarding its loan modification programs and delinquency rates [3][4]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the District of New Jersey on behalf of investors who purchased SLM securities between July 25, 2025, and August 14, 2025 [3]. - Allegations include violations of the Securities Exchange Act of 1934 by the Company and certain senior officers [3]. Group 2: Legal Actions and Deadlines - Investors wishing to serve as lead plaintiffs must file papers by February 17, 2026 [5]. - Participation as a lead plaintiff is not required to share in any potential recovery, and all representation is on a contingency fee basis [5]. Group 3: Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [6]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times [6].

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Klarna Group plc (NYSE: KLAR)? Did you purchase your shares pursuant or traceable to, the Company’s September 2025 IPO? Did you lose money in your investment in Klarna Group plc? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR) investors of an upcoming deadline involving a securities ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI) concerning misrepresentations made in the Registration Statement related to tenant demand at the Company's Project Matador campus [2][3]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Southern District of New York on behalf of investors who purchased or acquired Fermi securities during the Class Period from October 1, 2025, to December 11, 2025, and those who participated in the Company's October 2025 IPO [2]. - Allegations include violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 against Fermi and certain senior officers [2]. Group 2: Lead Plaintiff Information - Investors wishing to serve as lead plaintiff must file papers by March 6, 2026, with the role involving directing the litigation on behalf of other class members [4]. - Participation as a lead plaintiff is not required to share in any potential recovery, and all representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [5].

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Blue Owl Capital Inc. (NYSE: OWL)? Did you purchase your shares between February 6, 2025 and November 16, 2025, inclusive? Did you lose money in your investment in Blue Owl Capital Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) investors of an upcoming deadline involvin ...

Core Viewpoint - Bernstein Liebhard LLP is reminding investors of Vistagen Therapeutics, Inc. about a deadline related to a securities fraud class action lawsuit against the company [1]. Group 1: Lawsuit Details - A class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who purchased Vistagen common stock between April 1, 2024, and December 16, 2025, alleging violations of the Securities Exchange Act of 1934 [3]. - The lawsuit claims that the defendants made misrepresentations regarding the Company's Phase 3 PALISADE-3 trial study of fasedienol, which is being developed for the acute treatment of social anxiety disorder [4]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiff for the class must file papers by March 16, 2026, with the role involving directing the litigation on behalf of other class members [5]. - Participation as a lead plaintiff is not required to share in any potential recovery, and all representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]. Group 3: Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for its clients since 1993 and has represented both individual investors and large public and private pension funds [6]. - The firm has been recognized for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [6].

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Coupang, Inc. (NYSE: CPNG)? Did you purchase your shares between August 6, 2025 and December 16, 2025, inclusive? Did you lose money in your investment in Coupang, Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG) investors of an upcoming deadline involving a securities fraud clas ...

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of CoreWeave, Inc. (NASDAQ: CRWV)? Did you purchase your shares between March 28, 2025 and December 15, 2025, inclusive? Did you lose money in your investment in CoreWeave, Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds CoreWeave, Inc. (“CoreWeave” or the “Company”) (NASDAQ: CRWV) investors of an upcoming deadline involving a securitie ...

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.            The class action concerns whether Bath & Bod ...

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ: AQST).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Aquestive and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Ja ...